The latest price of Roprestimin/Romigrastim in 2025: How patients can choose the most economical treatment option

Romiplostim/Romiplostim, trade name: Vergel, is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP). While many patients are concerned about its efficacy, they are also very concerned about the price of the drug, especially how to obtain treatment at the most economical cost. This article will provide you with a detailed analysis of the price of Roprestimin from the aspects of domestic market prices, medical insurance policies and overseas drug purchase channels.

In China, the original drug of Roprostim has been successfully launched and has been included in the medical insurance catalog, which provides certain financial support to patients. However, although the drug has been included in medical insurance, due to its short time on the market, the purchase channels for Ropremilast are not wide enough, and the coverage of medical insurance reimbursement may be limited. For some patients, the actual cost of the drug remains higher.

In Hong Kong, the original drug price of Roprostim is approximately more than 9,000 yuan per tube. Since the price of the Hong Kong version is slightly lower, the price is about more than 8,000 yuan, and this price will change with exchange rate fluctuations. For patients who live in Hong Kong or need to purchase medications across the border, the price difference is also a factor to consider. At the same time, the price of the European and German versions of the original drug Roprostim is higher, with a single unit selling for about 10,000 yuan, and the price will also be affected by exchange rate changes.

Although the price of Roprostim varies due to regional and exchange rate changes, the main ingredients of the drug remain consistent globally, and there is no difference in efficacy and quality of drugs in different regions. It is worth noting that there are currently no generic drugs of Ropremilast on the market, which means that its price may not change much in the short term. Therefore, for patients, choosing appropriate purchasing channels, ensuring reliable drug sources, and taking into account medical insurance reimbursement policies are the keys to controlling treatment costs.

Reference materials:https://en.wikipedia.org/wiki/Romiplostim